Comparison of sample types for N-terminal pro-B-type natriuretic peptide measured on the siemens immulite 2500 and dimension vista LOCI methods

Annals of Clinical Biochemistry

Volumn 49, Issue 5, 2012, Pages 494-496

  Peake, Roy W A ^a   Turner, Helen E ^a   Leaper, Wendy ^a   Deans, Kevin A ^a   Hannah, Andrew ^a   Croal, Bernard L ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ANALYTICAL EQUIPMENT; ANALYZER; ARTICLE; BLOOD ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; HEART FAILURE; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

CLINICAL CHEMISTRY TESTS; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS;

EID: 84867178097     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2012.012053     Document Type: Article

References (9)

1. NICE Clinical Guideline 108. Chronic Heart Failure. Management of chronic heart failure in adults in primary and secondary care. London: NICE, August 2010
2. Hunt PJ, Espiner EA, Nicholls MG, Richards AM, Yandle TG. The role of circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32. Peptides 1997;18:1475-81
3. Yeo KT, Wu AHB, Apple FS, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 2003;338:107-15
4. Wu AH, Smith A, Wieczorek S, et al. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003;92:628-31
5. Seino Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail 2004;6:295-300
6. Analytical Characteristics of Commercial BNP and NT-proBNP Assays per Manufacturer. See http://www.ifcc.org/pdf/scientificactivities (last checked 9 February 2009)
7. Siemens Healthcare Diagnostics: IMMULITE® 2000 NT-proBNP. NY, USA: Siemens Healthcare Diagnostics. 2006: p2
8. Apple FS, Panteghini M, Ravkilde J, et al. Committee on Standardization of Markers of Cardiac Damage of the IFCC. Quality specifications for B-type natriuretic peptide assays. Clin Chem 2005;51:486-93
9. Al-Kindi M, Wigley N, Black M, Schneider HG. P56 Analytical performance of NT-proBNP on the Immulitew 2000. Clin Biochem Rev 2006;27:S40-1